ERBB2 and breast carcinoma: The Exo-miRNA signature in the plasma of patients with TNBC or HER2-positive breast cancer was significantly different from healthy controls, suggesting that exosomes might be useful in the diagnosis of breast cancer (Stevic et al., 2018) in addition to serving as effective delivery vehicles for tumor therapy.